Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study

BACKGROUND: Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This study aimed to compare the effectiveness of these two oral antiviral drugs in non-hospitalised and hospitalised patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Eric Yuk Fai, Yan, Vincent Ka Chun, Wong, Zoey Cho Ting, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Li, Xue, Wong, Carlos King Ho, Hung, Ivan Fan Ngai, Lau, Chak Sing, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518465/
https://www.ncbi.nlm.nih.gov/pubmed/37753272
http://dx.doi.org/10.1016/j.eclinm.2023.102225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518465/
https://www.ncbi.nlm.nih.gov/pubmed/37753272
http://dx.doi.org/10.1016/j.eclinm.2023.102225

Ejemplares similares